ACCORD HLTHCARE FDA Approval ANDA 216008

ANDA 216008

ACCORD HLTHCARE

FDA Drug Application

Application #216008

Application Sponsors

ANDA 216008ACCORD HLTHCARE

Marketing Status

Prescription001

Application Products

001SUSPENSION;ORAL2.5MG/ML0CLOBAZAMCLOBAZAM

FDA Submissions

UNKNOWN; ORIG1AP2022-09-06STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

ACCORD HLTHCARE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216008
            [companyName] => ACCORD HLTHCARE
            [docInserts] => ["",""]
            [products] => [{"drugName":"CLOBAZAM","activeIngredients":"CLOBAZAM","strength":"2.5MG\/ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/06\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-09-06
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.